Nova Eye Medical (ASX:EYE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Nova Eye Medical (ASX:EYE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Quarterly Activities/Appendix 4C Cash Flow Report
Nova Eye Medical reports 30% sales growth, positive EBITDA and A$0.5 million operating cash flow
Investor Webinar Monday 2 November @ 11.30 AEDT
Director Resignation
Change of Registry Address
Notice of General Meeting/Proxy Form
Cleansing Notice
Application for quotation of securities - EYE
Proposed issue of securities - EYE
AGM date and closing date for Director Nominations
Appendix 3 Y T A Spurling
Appendix 4G and Corporate Governance Statement
Full Year Financial Results
Nova Eye Medical reports FY26 sales growth and positive H2 EBITDA, reaffirms FY27 guidance
Appendix 4E and Annual Report
Nova Eye Medical reports 19% revenue growth and halves net loss in FY2026
Notification of cessation of securities - EYE
Investor Webinar Tuesday 4 August 2026 @ 11.30 AEST
Quarterly Activities/Appendix 4C Cash Flow Report
Nova Eye Medical reports 26% sales growth in FY26 and positive H2 EBITDA, guides for further growth in FY27